Hydrochloric Acid

Hydrochloric Acid

SCHEMBL25406366

CCCCN(CCCC)C(N(CCC)CCC)=[N+](CCCC)CCCC.[Cl-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA12 O43570 7/20 0.38
CA9 Q16790 7/20 0.38
CA1 P00915 6/20 0.38
ALDH1A1 P00352 1/20 0.38
ALDH2 P05091 1/20 0.38
CA2 P00918 5/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP8 P22894 1/20 0.35
SIGMAR1 Q99720 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1535756 0.96 CA12 (0.40) CA12CA9CA1ALDH1A1ALDH2
Hydrochloric Acid SCHEMBL6265698 0.94 CA12 (0.39) CA12CA9CA1ALDH1A1ALDH2
SCHEMBL1713038 0.94 CA12 (0.41) CA12CA9CA1ALDH1A1ALDH2
Hydrochloric Acid SCHEMBL25405638 0.92 CA12 (0.38) CA12CA9CA1ALDH1A1ALDH2
Iodide SCHEMBL7030478 0.91 CA12 (0.40) CA12CA9CA1ALDH1A1ALDH2
Fluoride Ion SCHEMBL5446663 0.91 CA12 (0.40) CA12CA9CA1ALDH1A1ALDH2
Bromide SCHEMBL6155069 0.91 CA12 (0.40) CA12CA9CA1ALDH1A1ALDH2
Hydrochloric Acid SCHEMBL25405687 0.90 CA12 (0.42) CA12CA9CA1ALDH1A1ALDH2
Hydrochloric Acid SCHEMBL14862018 0.90 CA12 (0.44) CA12CA9CA1ALDH1A1ALDH2
Hydrochloric Acid SCHEMBL29466158 0.89 CA12 (0.34) CA12CA9CA1ALDH1A1ALDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265113-A1 PROCESS FOR PREPARING POLYSULFANE SILANES BY MEANS OF PHASE TRANSFER CATALYSIS EVONIK OPERATIONS GMBH (DE) 2023-08-24 US claimed
CN-114195819-A Method for preparing polysulfanylsilanes by phase transfer catalysis 赢创运营有限公司 2022-03-18 CN claimed
US-20230265113-A1 PROCESS FOR PREPARING POLYSULFANE SILANES BY MEANS OF PHASE TRANSFER CATALYSIS EVONIK OPERATIONS GMBH (DE) 2023-08-24 US disclosed
CN-114195819-A Method for preparing polysulfanylsilanes by phase transfer catalysis 赢创运营有限公司 2022-03-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265113-A1 PROCESS FOR PREPARING POLYSULFANE SILANES BY MEANS OF PHASE TRANSFER CATALYSIS MRPS22, MRPS23, SRM CA12 1733/4885CA9 2048/4885CA1 1765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.